Tolerance in a concordant nonhuman primate model.

BACKGROUND We have previously demonstrated that induction of mixed lymphohematopoietic chimerism resulted in donor specific renal allograft tolerance without the need for chronic immunosuppression in nonhuman primates. Here we have tested whether tolerance can be similarly induced for baboon to cynomolgus renal xenografts. METHODS After preconditioning with anti-thymocyte globulin (ATG), nonlethal total body irradiation, and thymic irradiation, cynomolgus monkeys underwent splenectomy, native nephrectomies, and baboon marrow and renal transplants. Postoperative cyclosporine was given for 28 days. RESULTS In Group 1 (n=2, survival= 13, 14 days), both animals developed anti-donor immunoglobulin G, had biopsy findings consistent with humoral rejection, and showed rapidly progressive xenograft failure. In Group 2 (n=5, survival=1, 16, 33, 112, 190 days), 15-deoxyspergualine was added to the regimen (Day 0-13). In one long-term survivor, donor specific hyporesponsiveness was first observed (mixed lymphocyte culture [(MLR]) on Day 48. MLR reactivity returned on Day 64 together with the development of anti-donor antibody and subsequent xenograft failure on Day 112. Donor specific T-cell hyporesponsiveness was detected in the other long-term survivor for the first 133 days, after which a donor-specific skin xenograft was placed, (survival 24 days). Following the skin graft rejection, a rise in the MLR, development of anti-donor antibody and progressive rejection of the renal xenograft were observed. CONCLUSIONS Antibody-mediated rejection seems to constitute the major difference between concordant xenografts and allografts. Addition of 15-deoxyspergualine for 2 weeks posttransplant extended concordant primate xenograft survival to 6 months without chronic immunosuppression. In contrast to the allogeneic model, renal transplant acceptance in this xenogeneic system was interrupted by placement of a donor-specific skin graft.

[1]  R. Colvin,et al.  Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys , 1995, Transplantation.

[2]  R. Atkins,et al.  Deoxyspergualin suppresses local macrophage proliferation in rat renal allograft rejection. , 1994, Transplantation.

[3]  J. Wong,et al.  Characterization of a monoclonal antibody (6G12) recognizing the cynomolgus monkey CD3 antigen. , 1994, Transplantation proceedings.

[4]  T. Starzl,et al.  Baboon-to-human liver transplantation , 1993, The Lancet.

[5]  L. Peltonen,et al.  Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene , 1993, The Lancet.

[6]  S. Gruber,et al.  Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. , 1992, Transplantation.

[7]  S. Fu,et al.  Development and characterization of monoclonal antibodies to lymphocyte cell surface antigens of the rhesus monkey. , 1992, Transplantation.

[8]  D. Sachs,et al.  Effect of natural antibody on xenogeneic bone marrow engraftment. , 1992, Transplantation proceedings.

[9]  I. Bursuker,et al.  Inhibition of antibody production by the immunosuppressive agent, 15-deoxyspergualin. , 1991, Transplantation proceedings.

[10]  A. Hildebrandt,et al.  15‐DEOXYSPERGUALIN FOR INDUCTION OF GRAFT NONREACTIVITY AFTER CARDIAC AND RENAL ALLOTRANSPLANTATION IN PRIMATES , 1990, Transplantation.

[11]  M. Monden,et al.  EVIDENCE THAT DEOXYSPERGUALIN PREVENTS SENSITIZATION AND FIRST‐SET CARDIAC XENOGRAFT REJECTION IN RATS BY SUPPRESSION OF ANTIBODY FORMATION , 1990, Transplantation.

[12]  T. Sundt,et al.  Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen , 1990, The Journal of experimental medicine.

[13]  D. Sachs,et al.  Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen , 1989, The Journal of experimental medicine.

[14]  T. Aoyagi,et al.  Immunosuppressive activities of deoxyspergualin. II. The effect on the antibody responses. , 1987, Immunopharmacology.

[15]  H. Waldmann,et al.  Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance , 1986, Nature.

[16]  D. Sachs,et al.  Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts , 1984, Nature.

[17]  A. Singer,et al.  Self recognition in allogeneic radiation bone marrow chimeras. A radiation- resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells , 1981, The Journal of experimental medicine.

[18]  W. Paul,et al.  Role of T lymphocytes in the humoral immune response. I. Proliferation of B lymphocytes in thymus-deprived mice. , 1974, Journal of immunology.

[19]  R. Hewitt,et al.  RENAL HETEROTRANSPLANTATION IN MAN. , 1964, Annals of surgery.

[20]  K. Reemtsma Xenotransplantation — A Brief History of Clinical Experiences: 1900–1965 , 1991 .